Joint Computational-Experimental Discovery of Novel Dopamine D2 Receptor Partial Agonists and Biased Agonists toward Better Schizophrenia/Parkinson's Medications

Status	Finished
Effective start/end date	2/15/21 → 2/28/22

Project Details